Kalexo Bio

Explore the latest insights on Kalexo Bio and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Kalexo Bio’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Autobio Diagnostics and Haier Biomedical Sign Strategic Cooperation Agreement – AI‑Driven Alliance to Build Holistic Smart Laboratory Solutions Across IVD, Automation, and Medical Informatization
CompanyDeals

Autobio Diagnostics and Haier Biomedical Sign Strategic Cooperation Agreement – AI‑Driven Alliance to Build Holistic Smart Laboratory Solutions Across IVD, Automation, and Medical Informatization

Autobio Diagnostics Co., Ltd. (SHA: 603658) and Haier Biomedical (SHA: 688139) signed a strategic cooperation agreement, joining forces across in vitro diagnostics (IVD), laboratory automation, and medical informatization to drive…

TenNor Therapeutics Reports Multiple R&D Milestones for Rifasutenizol and Rifaquinone – NDA Supplementary Package Complete as First‑in‑Class Triple‑Target Agent Advances Against Device‑Associated Infections

TenNor Therapeutics Reports Multiple R&D Milestones for Rifasutenizol and Rifaquinone – NDA Supplementary Package Complete as First‑in‑Class Triple‑Target Agent Advances Against Device‑Associated Infections

CureGene Pharmaceutical and Walvax Biotechnology Sign Strategic MOU – Full‑Chain Alliance to Accelerate Innovative Nucleic Acid Drugs from AI‑Enabled mRNA R&D to Large‑Scale Manufacturing

CureGene Pharmaceutical and Walvax Biotechnology Sign Strategic MOU – Full‑Chain Alliance to Accelerate Innovative Nucleic Acid Drugs from AI‑Enabled mRNA R&D to Large‑Scale Manufacturing

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Mabwell Bioscience Teams With Aditum Bio to Launch Kalexo Bio, Inc., Targeting $1 B in Cardio siRNA Deal
CompanyDeals

Mabwell Bioscience Teams With Aditum Bio to Launch Kalexo Bio, Inc., Targeting $1 B in Cardio siRNA Deal